Syneos Health SYNH
$ 42.98
0.0%
Quarterly report 2023-Q1
added 05-10-2023
Country |
USA |
IPO year |
2014 |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBALSPB |
CEO |
Mr. Alistair Macdonald |
Employees in the company |
24 000 |
Shares |
104 M |
Market Cap[1] |
$ 4.46 B |
EBITDA (LTM) |
$ 391 M |
P/E (LTM) |
45.99 |
P/S (LTM) |
0.81 |
EPS (LTM) |
0.91 |
Other stocks of industry "Diagnostics research"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.